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Airborne transmission of infection is a critical concern in the
clinical environment with 10-33% of hospital-acquired
infections spread via air 1.
This study has successfully demonstrated the efficacy of
405nm light for inactivation of airborne bacteria, and
highlighted the enhanced susceptibility of bacterial aerosols.
Ø These findings enhance the value of 405nm light technology
for environmental decontamination, by demonstrating its
potential to inactivate aerial contamination.
1. Airborne bacteria were readily inactivated by 405nm
light.
2. Natural decay of the suspended aerosol was observed,
however this was significantly less than with light
treatment (P< 0.001).
3. Liquid suspended bacteria required a dose 3-4 times
greater to achieve an initial significant degree of
inactivation, and even greater for surfaces.
Fig. 3 Inactivation of aerosolized S. epidermidis by exposure to 405 nm 
light at an average irradiance of 22 mW cm-2. * represents significant 
inactivation when compared to associated non-exposed control samples. 
Ø Further work is required to fully characterize the dynamics of
airborne bacteria and to establish the efficacy of 405nm light
against natural aerial contamination.
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Fig. 6 Comparison of bacterial inactivation kinetics when exposed to ~22 
mW cm-2 405 nm light in air, in liquid and seeded onto surfaces.
Fig. 1 (A) 405 nm LED array (B) and optical emission spectrum of LED array.
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Air: Bacterial aerosols
were generated using
a 6-Jet Collison
nebulizer (12.5L/min)
& pumped into an
aerosol test chamber
(Fig 2).
Liquid: 3 mL volumes of bacteria suspended in PBS were
exposed to increasing doses of 405 nm light. Samples were
then plated, incubated & enumerated.
Surfaces: Bacteria were seeded onto agar plate surfaces and
exposed to increasing doses of 405 nm light. Samples were
then incubated and enumerated.
Light Source: The light source was an ENFIS PhotonStar
Innovate UNO 24 405 nm LED array (Fig 1). Average
irradiance was set at 22 mWcm-2. Dose (Jcm-2) was calculated
as irradiance (W cm-2)㽢time (s).
Fig. 2 Schematic system diagram. 4 additional LEDs 
were mounted to the chamber walls in addition to the 
top mounted light source.
(A) (B)
Fig. 4 Inactivation of liquid-suspended S. epidermidis by exposure to 405 
nm light at an average irradiance of 22 mW cm-2. * represents significant 
inactivation when compared to associated non-exposed control samples. 
RESULTS DISCUSSION
Fig. 5 Inactivation of surface-seeded S. epidermidis by exposure to 405 nm light at an average 
irradiance of 22 mW cm-2. (A) Quantitative inactivation kinetics and (B) qualitative results 
showing agar plates seeded with bacteria and exposed to increasing doses of light treatment.
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Violet-blue light has wide antimicrobial properties at
exposure levels that are non-harmful to human cells 2.
Its efficacy has been widely demonstrated against surface-
deposited and liquid-suspended bacteria, and is being
developed for clinical applications including wound
decontamination and environmental disinfection 3-6.
This study aims to establish the germicidal efficacy of
405nm violet-blue light against airborne bacteria and
compare susceptibility when exposed in liquid and surfaces.
Aerosols were exposed to increasing doses of 405nm light.
Air samples were removed from the chamber using a
BioSampler liquid impinger and the collection liquid was pour-
plated, incubated at 37¡C for 24h, and surviving bacteria
enumerated.
Vacuum 
pump
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Light 
Source
Nebulizer
Ø At a dose of 19.8 J cm-2, a 97.6% bacterial reduction was
achieved in air, and only 31.2% reduction in liquid.
Ø Due to high population densities, quantitative data on
surfaces was only available for doses >118.6 J cm-2.
Ø It is likely that surface inactivation kinetics would follow a
similar downward trend to that of liquids, or slower.
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